Safety is the result of design/understand the impact of the FDA guidelines for pharmaceutical industry
Drug design security considerations, in order to try to reduce medication errors: the United States center for drug evaluation and research (CDER), belonging to the United States food and drug administration (FDA), released in April 2016 file refers to an industry
South - the drug design of security considerations, to minimize medication errors ".This guide applies to all new drug applications (NDA), abbreviated new drug applications (ANDA), and OTC drugs.